Clinical trial
The Percutaneous Cholecystostomy is Appropriate as the Ultimate Treatment of Acute Cholecystitis in Critically Ill Patients: a Cross-sectional Study at Single Center.
NCT01894321 is registered in ClinicalTrials.gov with Cheju Halla General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Percutaneous Cholecystostomy is Appropriate as the Ultimate Treatment of Acute Cholecystitis in Critically Ill Patients: a Cross-sectional Study at Single Center.
- Lead sponsor
- Cheju Halla General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- December 31, 2012
- Enrollment
- 82 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute acalculous cholecystitis, acute calculous cholecystitis